Search research articles
Contact Us
Filters
Showing results (51-60 of 99) with videos related to
Page
of 10
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 31, 2022
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)
Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
British Journal of Haematology
|
February 13, 2003
Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomas
Chalid Assaf, Michael Hummel, Edgar Dippel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
July 31, 2007
Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG)
Chalid Assaf, Sylke Gellrich, Matthias Steinhoff, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2017
PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma
Katrin Schaper-Gerhardt, Steven Okoye, Rudolf Herbst, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 28, 2024
S1-Guideline Sebaceous Carcinoma
Jochen Utikal, Pia Nagel, Verena Müller, et al.
Dermatologie (Heidelberg, Germany)
|
October 10, 2024
[Effects of the COVID-19 pandemic on inpatient dermatosurgery in Germany : Retrospective evaluation of the surgical cases from nine dermatology clinics]
Galina Balakirski, Chalid Assaf, Edgar Dippel, et al.
Cancers
|
January 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network
Christoph Blazejak, Mathias Oymanns, René Stranzenbach, et al.
Journal of Translational Medicine
|
November 7, 2015
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
Lisa Zimmer, Thomas K Eigentler, Felix Kiecker, et al.
Blood
|
May 22, 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P Nicolay, Susanne Melchers, Jana D Albrecht, et al.
Cancer Immunology, Immunotherapy : CII
|
June 14, 2016
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis
Markus V Heppt, Thomas K Eigentler, Katharina C Kähler, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 99) with videos related to
Sort By:
Page
of 10
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 31, 2022
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)
Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
British Journal of Haematology
|
February 13, 2003
Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomas
Chalid Assaf, Michael Hummel, Edgar Dippel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
July 31, 2007
Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG)
Chalid Assaf, Sylke Gellrich, Matthias Steinhoff, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2017
PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma
Katrin Schaper-Gerhardt, Steven Okoye, Rudolf Herbst, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 28, 2024
S1-Guideline Sebaceous Carcinoma
Jochen Utikal, Pia Nagel, Verena Müller, et al.
Dermatologie (Heidelberg, Germany)
|
October 10, 2024
[Effects of the COVID-19 pandemic on inpatient dermatosurgery in Germany : Retrospective evaluation of the surgical cases from nine dermatology clinics]
Galina Balakirski, Chalid Assaf, Edgar Dippel, et al.
Cancers
|
January 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network
Christoph Blazejak, Mathias Oymanns, René Stranzenbach, et al.
Journal of Translational Medicine
|
November 7, 2015
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
Lisa Zimmer, Thomas K Eigentler, Felix Kiecker, et al.
Blood
|
May 22, 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P Nicolay, Susanne Melchers, Jana D Albrecht, et al.
Cancer Immunology, Immunotherapy : CII
|
June 14, 2016
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis
Markus V Heppt, Thomas K Eigentler, Katharina C Kähler, et al.
Page
of 10